An evaluation of the spread and scale of PatientToc™ from primary care to community pharmacy practice for the collection of patient-reported outcomes: A study protocol.
An evaluation of the spread and scale of PatientToc™ from primary care to community pharmacy practice for the collection of patient-reported outcomes: A study protocol.
复制标题
从初级保健到社区药房实践的患者预期结果的评估和规模的评估：研究方案。
DOI：
10.1016/j.sapharm.2020.03.019
复制
发表时间：
2021-03
期刊：
影响因子：
--
通讯作者：
Curran GM
中科院分区：
文献类型：
--
作者：
Snyder ME;Chewning B;Kreling D;Perkins SM;Knox LM;Adeoye-Olatunde OA;Jaynes HA;Schommer JC;Murawski MM;Sangasubana N;Hillman LA;Curran GM
药物不依从性是一个至关重要的问题，影响了大约50%的服用至少一种定期处方药的人，每年给美国造成超过1000亿美元的损失。用于识别和解决社区药房中的药物不依从性的传统数据源包括处方填充历史。然而，拥有药物并不一定意味着患者正在按处方服用药物。患者报告的结果（PRO），测量与服药的记忆和意图有关的依从性挑战，为药剂师和处方师提供了丰富的数据源，用于解决药物不依从性。PatientToc™是一种PRO收集软件，旨在促进从洛杉矶的低识字率和非英语患者中收集PRO数据。本研究将评估PatientToc™从初级保健到社区药房的传播和规模，以收集和使用与药物依从性有关的PRO数据。将采取以下实施和评价步骤：1）实施前发展形成性评估，以确定社区药房工作流程和当前实践，用于识别和解决药物不依从性、PatientToc™实施的潜在障碍和促进因素，并创建实施工具包草案，2）两个计划-实施-研究-行动周期，以完善在社区药房推广和扩大PatientToc™实施的实施工具包，以及3）对护理质量进行全面的、理论驱动的评估，实施，以及将PatientToc™推广和扩展到社区药房的患者健康结果。这项研究将为社区药房长期收集和使用与药物依从性有关的PRO数据提供信息。
Medication non-adherence is a problem of critical importance, affecting approximately 50% of all persons taking at least one regularly scheduled prescription medication and costing the United States more than $100 billion annually. Traditional data sources for identifying and resolving medication non-adherence in community pharmacies include prescription fill histories. However, medication possession does not necessarily mean patients are taking their medications as prescribed. Patient-reported outcomes (PROs), measuring adherence challenges pertaining to both remembering and intention to take medication, offer a rich data source for pharmacists and prescribers to use to resolve medication non-adherence. PatientToc™ is a PROs collection software developed to facilitate collection of PROs data from low-literacy and non-English speaking patients in Los Angeles. This study will evaluate the spread and scale of PatientToc™ from primary care to community pharmacies for the collection and use of PROs data pertaining to medication adherence. The following implementation and evaluation steps will be conducted: 1) a pre-implementation developmental formative evaluation to determine community pharmacy workflow and current practices for identifying and resolving medication non-adherence, potential barriers and facilitators to PatientToc™ implementation, and to create a draft implementation toolkit, 2) two plan-do-study-act cycles to refine an implementation toolkit for spreading and scaling implementation of PatientToc™ in community pharmacies, and 3) a comprehensive, theory-driven evaluation of the quality of care, implementation, and patient health outcomes of spreading and scaling PatientToc™ to community pharmacies. This research will inform long-term collection and use of PROs data pertaining to medication adherence in community pharmacies.
登录
查看更多内容
影响因子：
3
作者：
Jensen RE;Rothrock NE;DeWitt EM;Spiegel B;Tucker CA;Crane HM;Forrest CB;Patrick DL;Fredericksen R;Shulman LM;Cella D;Crane PK
通讯作者：
Crane PK
影响因子：
2.8
作者：
Jahagirdar D;Kroll T;Ritchie K;Wyke S
通讯作者：
Wyke S
DOI：
10.1186/1748-5908-4-50
发表时间：
2009-08-07
期刊：
Implementation science : IS
影响因子：
--
作者：
Damschroder LJ;Aron DC;Keith RE;Kirsh SR;Alexander JA;Lowery JC
通讯作者：
Lowery JC
DOI：
10.1136/amiajnl-2012-001272
发表时间：
2013-05-01
影响因子：
6.4
作者：
McDonald, Margaret V.;Peng, Timothy R.;Feldman, Penny H.
通讯作者：
Feldman, Penny H.
影响因子：
2.5
作者：
Fortney, John C.;Pyne, Jeffrey M.;McDougall, Skye
通讯作者：
McDougall, Skye